$35 million gift from Douglas and Diana Berthiaume to university will establish a new center for biomedical discovery, raises their giving to more than $90 million
The University of Notre Dame has received a transformative $35 million commitment from longtime benefactors Douglas and Diana Berthiaume, a gift that will establish a new Center for Biomedical Discovery and significantly expand the university’s capacity for interdisciplinary research at the intersection of science, engineering, and human health.
The Berthiaumes’ philanthropy reflects a sustained and deeply considered commitment to advancing scientific discovery through collaboration, with this latest investment designed to accelerate innovation across traditionally siloed academic disciplines.
Their gift will support critical infrastructure, cutting-edge technologies, and the integration of expertise across Notre Dame’s College of Science and College of Engineering—an approach increasingly recognized as essential to addressing complex biomedical challenges.
For Douglas Berthiaume, former chairman and chief executive officer of Waters Corporation, and Diana Berthiaume, a dedicated philanthropist with a longstanding engagement in education and community initiatives, the center represents more than a capital investment.
It embodies a philosophy of giving that prioritizes catalytic impact—supporting environments where researchers can move more fluidly from fundamental discovery to real-world application.
University leadership noted that the Center for Biomedical Discovery will serve as a hub for collaborative inquiry, enabling faculty, students, and research teams to pursue breakthroughs in areas such as disease detection, therapeutic development, and advanced diagnostics.
By investing in shared facilities and emerging technologies, the Berthiaumes are helping to remove structural barriers that often limit the pace and scope of scientific progress.
The couple’s philanthropic history with Notre Dame underscores a consistent focus on empowering research and education.
Their giving has previously supported initiatives that elevate academic excellence and foster innovation, and this latest contribution builds on that legacy with a forward-looking emphasis on health-related discovery.
It also reflects a broader trend among leading donors, who are increasingly directing resources toward interdisciplinary models that can yield faster, more scalable outcomes.
In announcing the gift, the university emphasized that the center will not only enhance Notre Dame’s research capabilities but also position it as a more prominent contributor to the global biomedical ecosystem.
The Berthiaumes’ investment is expected to attract additional talent, partnerships, and funding, creating a multiplier effect that extends well beyond the initial $35 million commitment.
At its core, the gift speaks to the Berthiaumes’ belief in the power of academic institutions to drive meaningful societal impact.
By focusing on infrastructure that enables collaboration and discovery, they are supporting a model of philanthropy that prioritizes long-term value creation—laying the groundwork for scientific advances that could improve health outcomes for generations.
Their contribution arrives at a moment when the importance of biomedical innovation remains sharply in focus and when universities are seeking new ways to align research with urgent global needs.
Through the Center for Biomedical Discovery, Douglas and Diana Berthiaume have positioned Notre Dame to play a more consequential role in that effort, reinforcing the enduring influence of strategic, thoughtfully directed philanthropy.